"Lymph Node Excision" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966)
| Descriptor ID |
D008197
|
| MeSH Number(s) |
E04.446
|
| Concept/Terms |
Lymph Node Excision- Lymph Node Excision
- Excision, Lymph Node
- Excisions, Lymph Node
- Lymph Node Excisions
- Lymphadenectomy
- Lymphadenectomies
Lymph Node Dissection- Lymph Node Dissection
- Dissection, Lymph Node
- Dissections, Lymph Node
- Lymph Node Dissections
- Node Dissection, Lymph
- Node Dissections, Lymph
|
Below are MeSH descriptors whose meaning is more general than "Lymph Node Excision".
Below are MeSH descriptors whose meaning is more specific than "Lymph Node Excision".
This graph shows the total number of publications written about "Lymph Node Excision" by people in this website by year, and whether "Lymph Node Excision" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 3 | 4 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 5 | 6 |
| 2004 | 3 | 0 | 3 |
| 2005 | 2 | 3 | 5 |
| 2006 | 2 | 0 | 2 |
| 2007 | 5 | 2 | 7 |
| 2008 | 4 | 1 | 5 |
| 2009 | 6 | 2 | 8 |
| 2010 | 5 | 0 | 5 |
| 2012 | 7 | 4 | 11 |
| 2013 | 7 | 7 | 14 |
| 2014 | 0 | 4 | 4 |
| 2015 | 4 | 4 | 8 |
| 2016 | 7 | 4 | 11 |
| 2017 | 6 | 6 | 12 |
| 2018 | 6 | 2 | 8 |
| 2019 | 6 | 7 | 13 |
| 2020 | 2 | 5 | 7 |
| 2021 | 0 | 3 | 3 |
| 2022 | 0 | 4 | 4 |
| 2023 | 1 | 6 | 7 |
| 2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymph Node Excision" by people in Profiles.
-
Primary retroperitoneal lymph node dissection in clinical stage 2a/b non-seminomatous germ cell tumour. BJU Int. 2025 Apr; 135(4):621-628.
-
Geographic and racial disparities in the quality of surgical care among patients with nonmetastatic uterine cancer. Am J Obstet Gynecol. 2025 Mar; 232(3):308.e1-308.e15.
-
Personalizing Locoregional Therapy in Patients With Breast Cancer in 2024: Tailoring Axillary Surgery, Escalating Lymphatic Surgery, and Implementing Evidence-Based Hypofractionated Radiotherapy. Am Soc Clin Oncol Educ Book. 2024 Jun; 44(3):e438776.
-
Efficacy of Targeted Axillary Dissection With Radar Reflector Localization Before Neoadjuvant Chemotherapy. J Surg Res. 2024 Mar; 295:597-602.
-
Establishment and Feasibility of an Immediate Lymphatic Reconstruction Program in a Community Health System. Ann Surg Oncol. 2024 Jan; 31(1):672-680.
-
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer. J Clin Oncol. 2023 Dec 01; 41(34):5296-5305.
-
Evaluation of Nationwide Trends in Nodal Sampling Guideline Adherence for Gastric Cancer: 2005-2017. J Surg Res. 2023 11; 291:514-526.
-
Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma. Ann Surg Oncol. 2023 07; 30(7):4359-4360.
-
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy. J Clin Oncol. 2023 06 01; 41(16):3009-3018.
-
Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study. Eur J Cancer. 2023 03; 182:144-154.